Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
1.
Antonie Van Leeuwenhoek ; 113(2): 233-252, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31560092

RESUMEN

Our aim was to identify less common non-fermenting gram-negative rods during the bioremediation process. Five genera were found: Advenella, Castellaniella, Kaistia, Pusillimonas and Sphingobacterium, for a total of 15 isolates. Therefore, we evaluated the applicability of four methods currently available for bacteria identification: (1) conventional biochemical methods, (2) the VITEK®-2 system, (3) MALDI-TOF mass spectrometry and (4) 16S rRNA gene sequencing. The biochemical methods and the VITEK®-2 system were reliable only for the Sphingobacterium isolate and solely at the genus level. Both MALDI-TOF mass spectrometry platforms (Bruker and VITEK® MS) did not achieve reliable identification results for any of these genera. 16S rRNA gene sequencing identified eight isolates to the species level but not to the subspecies level, when applicable. The remaining seven isolates were reliably identified through 16S rRNA gene sequencing to the genus level only. Our findings suggest that the detection and identification of less common genera (and species) that appeared at certain moments during the bioremediation process can be a challenge to microbiologists considering the most used techniques. In addition, more studies are required to confirm our results.


Asunto(s)
Alcaligenaceae/genética , Rhizobiaceae/genética , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Sphingobacterium/genética , Alcaligenaceae/clasificación , Técnicas de Tipificación Bacteriana , ARN Ribosómico 16S/genética , Rhizobiaceae/clasificación , Sphingobacterium/clasificación
4.
Antimicrob Agents Chemother ; 60(1): 686-8, 2016 01.
Artículo en Inglés | MEDLINE | ID: mdl-26552984

RESUMEN

In this work, we demonstrate that the fosI gene encodes a predicted small protein with 134 amino acids and determines reduced susceptibility to fosfomycin. It raised the MIC from 0.125 to 6 µg/ml when the pBRA100 plasmid was introduced into Escherichia coli TOP10 and to 16 µg/ml when the gene was cloned into the pBC_SK(-) vector and expressed in E. coli TOP10.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana/genética , Escherichia coli/genética , Fosfomicina/farmacología , Integrones , Secuencia de Aminoácidos , Escherichia coli/efectos de los fármacos , Escherichia coli/metabolismo , Expresión Génica , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Plásmidos/química , Plásmidos/metabolismo , Alineación de Secuencia , Transformación Bacteriana
5.
Antimicrob Agents Chemother ; 59(12): 7387-95, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26392506

RESUMEN

In Enterobacteriaceae, the blaNDM genes have been found in many different genetic contexts, and a wide diversity of plasmid scaffolds bearing those genes has been found. In August 2013, we identified NDM-1-producing Escherichia coli and Enterobacter hormaechei strains from a single rectal swab sample from a patient hospitalized in Rio de Janeiro, Brazil, who had no history of travel abroad. Complete DNA sequencing using the Illumina platform and annotation of the two plasmids harboring the blaNDM-1 gene, one from each strain, showed that they belonged to incompatibility groups IncFIIK and IncX3 and harbored a novel transposon named Tn3000. Similar genetic structures have been identified among other isolates in Brazil but also on plasmids from other continents. Our findings suggest that the blaNDM-1 gene may be transmitted by Tn3000 in different parts of the world.


Asunto(s)
Elementos Transponibles de ADN/genética , Enterobacter/aislamiento & purificación , Escherichia coli/aislamiento & purificación , beta-Lactamasas/metabolismo , Antibacterianos/farmacología , Aztreonam/farmacología , Proteínas Bacterianas/genética , Secuencia de Bases , Brasil , Conjugación Genética , Secuencia Conservada , Enterobacter/efectos de los fármacos , Enterobacter/genética , Enterobacter/metabolismo , Infecciones por Enterobacteriaceae/microbiología , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Escherichia coli/metabolismo , Fosfomicina/farmacología , Humanos , India , Pruebas de Sensibilidad Microbiana , Marruecos , Nepal , Plásmidos , Recto/microbiología , beta-Lactamasas/genética
6.
Int J Mol Sci ; 16(3): 6337-52, 2015 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-25809608

RESUMEN

The growing challenge of antimicrobial resistance to antibiotics requires novel synthetic drugs or new formulations for old drugs. Here, cationic nanostructured particles (NPs) self-assembled from cationic bilayer fragments and polyelectrolytes are tested against four multidrug-resistant (MDR) strains of clinical importance. The non-hemolytic poly(diallyldimethylammonium) chloride (PDDA) polymer as the outer NP layer shows a remarkable activity against these organisms. The mechanism of cell death involves bacterial membrane lysis as determined from the leakage of inner phosphorylated compounds and possibly disassembly of the NP with the appearance of multilayered fibers made of the NP components and the biopolymers withdrawn from the cell wall. The NPs display broad-spectrum activity against MDR microorganisms, including Gram-negative and Gram-positive bacteria and yeast.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Polietilenos/farmacología , Compuestos de Amonio Cuaternario/farmacología
7.
Antimicrob Agents Chemother ; 58(5): 2958-60, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24566176

RESUMEN

We sequenced the oldest blaKPC-2-bearing plasmid isolated in Brazil and another plasmid also carried by a Klebsiella pneumoniae strain of sequence type 442 (ST442), isolated 52 months later. Both plasmids present an IncN backbone and few acquired regions. Because the 2005 plasmid presented deletions and a truncated gene within Tn4401b compared to the 2009 plasmid, we can thus infer that IncN blaKPC-2-bearing plasmids pFCF1305 and pFCF3SP had a common ancestor circulating in Brazil prior to May 2005.


Asunto(s)
Klebsiella pneumoniae/enzimología , Klebsiella pneumoniae/genética , Plásmidos/genética , Brasil , Farmacorresistencia Bacteriana Múltiple/genética , beta-Lactamasas/genética
8.
Lancet Microbe ; 5(3): e282-e290, 2024 03.
Artículo en Inglés | MEDLINE | ID: mdl-38432234

RESUMEN

BACKGROUND: Zoonotic sporotrichosis is a neglected fungal disease, whereby outbreaks are primarily driven by Sporothrix brasiliensis and linked to cat-to-human transmission. To understand the emergence and spread of sporotrichosis in Brazil, the epicentre of the current epidemic in South America, we aimed to conduct whole-genome sequencing (WGS) to describe the genomic epidemiology. METHODS: In this genomic epidemiology study, we included Sporothrix spp isolates from sporotrichosis cases from Brazil, Colombia, and the USA. We conducted WGS using Illumina NovaSeq on isolates collected by three laboratories in Brazil from humans and cats with sporotrichosis between 2013 and 2022. All isolates that were confirmed to be Sporothrix genus by internal transcribed spacer or beta-tubulin PCR sequencing were included in this study. We downloaded eight Sporothrix genome sequences from the National Center for Biotechnology Information (six from Brazil, two from Colombia). Three Sporothrix spp genome sequences from the USA were generated by the US Centers for Disease Control and Prevention as part of this study. We did phylogenetic analyses and correlated geographical and temporal case distribution with genotypic features of Sporothrix spp isolates. FINDINGS: 72 Sporothrix spp isolates from 55 human and 17 animal sporotrichosis cases were included: 67 (93%) were from Brazil, two (3%) from Colombia, and three (4%) from the USA. Cases spanned from 1999 to 2022. Most (61 [85%]) isolates were S brasiliensis, and all were reported from Brazil. Ten (14%) were Sporothrix schenckii and were reported from Brazil, USA, and Colombia. For S schenckii isolates, two distinct clades were observed wherein isolates clustered by geography. For S brasiliensis isolates, five clades separated by more than 100 000 single-nucleotide polymorphisms were observed. Among the five S brasiliensis clades, clades A and C contained isolates from both human and cat cases, and clade A contained isolates from six different states in Brazil. Compared with S brasiliensis isolates, larger genetic diversity was observed among S schenckii isolates from animal and human cases within a clade. INTERPRETATION: Our results suggest that the ongoing epidemic driven by S brasiliensis in Brazil represents several, independent emergence events followed by animal-to-animal and animal-to human transmission within and between Brazilian states. These results describe how S brasiliensis can emerge and spread within a country. FUNDING: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil; the São Paulo Research Foundation; Productivity in Research fellowships by the National Council for Scientific and Technological Development, and Ministry of Science and Technology of Brazil.


Asunto(s)
Sporothrix , Esporotricosis , Animales , Humanos , Esporotricosis/epidemiología , Esporotricosis/veterinaria , Esporotricosis/microbiología , Brasil/epidemiología , Filogenia , Brotes de Enfermedades , Genómica , Sporothrix/genética
10.
Microbiol Spectr ; 11(1): e0117922, 2023 02 14.
Artículo en Inglés | MEDLINE | ID: mdl-36688721

RESUMEN

In 2015, two new species related to the Staphylococcus aureus were proposed. We describe five isolates of the new species Staphylococcus argenteus cultured from human cases of bacteremia and skin and soft tissue infections. This is the first report of S. argenteus, from South America, causing community-acquired and nosocomial infections.


Asunto(s)
Infecciones Comunitarias Adquiridas , Infecciones Estafilocócicas , Humanos , Brasil/epidemiología , Staphylococcus , Infecciones Estafilocócicas/epidemiología , Staphylococcus aureus , Infecciones Comunitarias Adquiridas/epidemiología
11.
Antimicrob Agents Chemother ; 56(2): 1116-9, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22083487

RESUMEN

Broad-host-range plasmid pRIO-5, harboring the extended-spectrum ß-lactamase bla(BES-1) gene in Serratia marcescens, was fully sequenced. Analysis of the 12,957-bp sequence of this IncP6-type plasmid revealed that the bla(BES-1) gene was associated with two copies of the insertion sequence IS26. The promoter responsible for the bla(BES-1) expression was hybrid, made of a -35 box located inside the inverted repeat of IS26 and a -10 box inside a remnant of an insertion sequence.


Asunto(s)
Acinetobacter baumannii/efectos de los fármacos , Escherichia coli/genética , Plásmidos/genética , Análisis de Secuencia de ADN , Serratia marcescens/genética , beta-Lactamasas/genética , Acinetobacter baumannii/genética , Antibacterianos/farmacología , Elementos Transponibles de ADN/genética , Escherichia coli/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Plásmidos/química , Serratia marcescens/efectos de los fármacos , beta-Lactamasas/metabolismo , beta-Lactamas/farmacología
12.
J Glob Antimicrob Resist ; 28: 49-52, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34936924

RESUMEN

OBJECTIVES: The aim of this study was to describe a simple test to predict in vitro efficacy of aztreonam/avibactam (ATM-AVI) combination based on a pre-diffusion assay involving routinely available ceftazidime/avibactam (CAZ-AVI) and aztreonam (ATM) disks. METHODS: A total of 113 non-repetitive NDM-producing Klebsiella had the species identified by multiplex PCR. Minimum inhibitory concentrations (MICs) for ATM and ATM-AVI were determined by broth microdilution. For the combined disk pre-diffusion method, a disk containing ceftazidime 10 µg and avibactam 4 µg (CAZ-AVI) was applied on the surface of an uninoculated Mueller-Hinton agar plate. Following incubation for 2 h at 36°C, the disk was removed, the bacterial suspension was applied and a 30 µg ATM disk was placed precisely in the same position as the removed CAZ-AVI disk. Following incubation for 16-20 h, inhibition zone diameters were measured and correlated with ATM-AVI MICs. RESULTS: The distribution of species among the 113 isolates was 85 Klebsiella pneumoniae (75.2%), 19 Klebsiella quasipneumoniae (16.8%) and 9 Klebsiella variicola (8.0%). A total of 99 isolates had only blaNDM and 14 had both blaNDM and blaKPC genes. Regarding the isolates positive for blaNDM only, 38.4% were susceptible to ATM and 7.1% were susceptible, increased exposure. All isolates had ATM-AVI MICs of ≤1 mg/L, and the smallest inhibition zone diameter observed was 23 mm. CONCLUSION: Modified disk pre-diffusion can be used as a simple test to screen for ATM-AVI in vitro activity against Klebsiella, since ATM-AVI disks, gradient strips or microdilution panels are not commercially available.


Asunto(s)
Aztreonam , Ceftazidima , Antibacterianos/farmacología , Compuestos de Azabiciclo , Aztreonam/farmacología , Ceftazidima/farmacología , Cefalosporinas , Klebsiella pneumoniae/genética
14.
Braz J Microbiol ; 52(4): 1981-1989, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34460074

RESUMEN

Polymyxins are still used mainly in treating infections caused by carbapenem-resistant Klebsiella pneumoniae worldwide. The most frequent mechanism of acquired resistance to polymyxins in Gram-negative bacilli is the occurrence of mutations in chromosomal genes regulating operons responsible for lipopolysaccharide modification. As we observed at Santa Casa de São Paulo hospital the occurrence of infections caused by isolates resistant to polymyxins in patients previously treated with this antimicrobial, and new infections caused by the same polymyxin-susceptible species, in this study, we aimed to determine the clonality of consecutive K. pneumoniae isolates from the same patients and characterize the molecular determinants of polymyxin resistance in paired or clonal isolates. A total of 24 pairs and one trio of K. pneumoniae isolates were included in this study. Species identification was achieved by mass spectrometry and multiplex PCR. Polymyxin B minimal inhibitory concentrations were determined by broth microdilution. Clonality was evaluated using pulsed-field gel electrophoresis. The presence of insertions in mgrB gene was tested by PCR, and mutations on pmrA, pmrB, phoP, and phoQ were evaluated by PCR and complete nucleotide sequencing. A fraction of 23.8% of strains resistant to polymyxin B had an insertion in mgrB. Amino acid substitution F204L in PmrB may be implicated in polymyxin resistance. Substitutions T246A and R256G in PmrB were not implicated in polymyxin resistance. In this study, polymyxin resistance after a first susceptible isolate was detected was most frequently due to an infection caused by a distinct clone.


Asunto(s)
Proteínas Bacterianas , Farmacorresistencia Bacteriana , Infecciones por Klebsiella , Klebsiella pneumoniae , Polimixina B , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Brasil , Farmacorresistencia Bacteriana/genética , Genotipo , Humanos , Infecciones por Klebsiella/microbiología , Klebsiella pneumoniae/efectos de los fármacos , Klebsiella pneumoniae/genética , Pruebas de Sensibilidad Microbiana , Polimixina B/farmacología
15.
Artículo en Inglés | MEDLINE | ID: mdl-32876297

RESUMEN

An outbreak of bloodstream infection (BSI) caused by members of the Burkholderia cepacia complex (Bcc) took place from March 2012 until April 2014 involving thirteen patients. AIM: To describe an outbreak investigation of BSI Bcc and showing how genetic sequencing tools contributed to confirm the hypothesis of extrinsic contamination proposed by an observational study. METHODS: The Infection Control Department revised and reinforced good practices of infusion therapy and catheter care, visits to affected wards, a case control study, and environmental screening based on the case-control findings. RESULTS: Data from the case-control study found an association of cases with central venous catheter (OR 1.36; CI 1.15-1.67) and intravenous cisatracurium use (OR 10.75; CI 1.67-68.89). Visits to the operatory block revealed problems related to the cold chain used for the preservation of thermolabile cisatracurium. We could not retrieve Bcc from environmental samples using classic microbiology. New samples from the same surfaces were obtained for genetic sequencing. Bcc was identified in the cooler box, refrigerator and reusable ice packages. CONCLUSION: Environmental screening using genetic sequencing proved to be a useful tool for confirming our hypothesis of extrinsic contamination raised by the case-control study.


Asunto(s)
Bacteriemia , Infecciones por Burkholderia/diagnóstico , Complejo Burkholderia cepacia/aislamiento & purificación , Infección Hospitalaria , Infecciones por Burkholderia/epidemiología , Complejo Burkholderia cepacia/genética , Estudios de Casos y Controles , Brotes de Enfermedades , Humanos , Secuenciación del Exoma
16.
J Clin Microbiol ; 47(7): 2149-55, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19403765

RESUMEN

An epidemic of infections after video-assisted surgery (1,051 possible cases) caused by rapidly growing mycobacteria (RGM) and involving 63 hospitals in the state of Rio de Janeiro, Brazil, occurred between August 2006 and July 2007. One hundred ninety-seven cases were confirmed by positive acid-fast staining and/or culture techniques. Thirty-eight hospitals had cases confirmed by mycobacterial culture, with a total of 148 available isolates recovered from 146 patients. Most (n = 144; 97.2%) isolates presented a PRA-hsp65 restriction pattern suggestive of Mycobacterium bolletii or Mycobacterium massiliense. Seventy-four of these isolates were further identified by hsp65 or rpoB partial sequencing, confirming the species identification as M. massiliense. Epidemic isolates showed susceptibility to amikacin (MIC at which 90% of the tested isolates are inhibited [MIC(90)], 8 microg/ml) and clarithromycin (MIC(90), 0.25 microg/ml) but resistance to ciprofloxacin (MIC(90), >or=32 microg/ml), cefoxitin (MIC(90), 128 microg/ml), and doxycycline (MIC(90), >or=64 microg/ml). Representative epidemic M. massiliense isolates that were randomly selected, including at least one isolate from each hospital where confirmed cases were detected, belonged to a single clone, as indicated by the analysis of pulsed-field gel electrophoresis (PFGE) patterns. They also had the same PFGE pattern as that previously observed in two outbreaks that occurred in other Brazilian cities; we designated this clone BRA100. All five BRA100 M. massiliense isolates tested presented consistent tolerance to 2% glutaraldehyde. This is the largest epidemic of postsurgical infections caused by RGM reported in the literature to date in Brazil.


Asunto(s)
Infección Hospitalaria/epidemiología , Brotes de Enfermedades , Infecciones por Mycobacterium/epidemiología , Mycobacterium/aislamiento & purificación , Infección de la Herida Quirúrgica/epidemiología , Adulto , Proteínas Bacterianas/genética , Técnicas de Tipificación Bacteriana , Brasil/epidemiología , Chaperonina 60 , Chaperoninas/genética , Análisis por Conglomerados , Infección Hospitalaria/microbiología , Dermatoglifia del ADN , ADN Bacteriano/química , ADN Bacteriano/genética , ARN Polimerasas Dirigidas por ADN/genética , Electroforesis en Gel de Campo Pulsado , Femenino , Genotipo , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Epidemiología Molecular , Datos de Secuencia Molecular , Mycobacterium/clasificación , Infecciones por Mycobacterium/microbiología , Análisis de Secuencia de ADN , Infección de la Herida Quirúrgica/microbiología
17.
Braz J Microbiol ; 50(1): 127-132, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30637648

RESUMEN

Carba-NP original report for blood cultures described the need of subculture and mechanical lysis before testing, reaching the turnaround time of approximately 4 hours for sample preparation. We tested 100 consecutive blood cultures positive for Gram-negative bacilli on the Gram stain from a large clinical laboratory. Bacterial pellets were prepared by centrifugation and submitted to Carba-NP and Blue-Carba tests and used further to prepare smears for Vitek MS. Results obtained with colonies grown on sheep blood agar using the same methodologies were used as the gold standard. Carbapenemase genes were confirmed by PCR and DNA sequencing. Vitek MS identified correctly 86% of the samples. Of note, 7% of the samples were incorrectly reported by the instrument as containing a single isolate. KPC-2 was the predominant carbapenemase detected. There was 100% concordance for both negative and positive results for Carba-NP. In contrast, for Blue-Carba the concordance for positive results was 92.8%, and 41% of strains negative for carbapenemases presented a yellowish color on control well turning the test non-interpretable. The turnaround time for sample preparation for preparing the pellet was 13 min, and no subculture or mechanical lysis is needed when detecting KPC production in Enterobacterales.


Asunto(s)
Proteínas Bacterianas/metabolismo , Cultivo de Sangre/métodos , Infecciones por Enterobacteriaceae/sangre , Enterobacteriaceae/aislamiento & purificación , Proteínas Bacterianas/genética , Enterobacteriaceae/clasificación , Enterobacteriaceae/genética , Infecciones por Enterobacteriaceae/diagnóstico , Infecciones por Enterobacteriaceae/microbiología , Humanos , Reacción en Cadena de la Polimerasa , Sensibilidad y Especificidad , Flujo de Trabajo , beta-Lactamasas/genética , beta-Lactamasas/metabolismo
19.
Diagn Microbiol Infect Dis ; 55(2): 107-18, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16529900

RESUMEN

Outbreaks of rapidly growing mycobacterium (RGM) infections are increasingly being reported worldwide. Information about genetic relatedness of isolates obtained during outbreaks can provide opportunities for prompt intervention. Pulsed-field gel electrophoresis (PFGE) is expensive, time consuming, and labor intensive. Other than that, Mycobacterium abscessus isolates can suffer DNA degradation during electrophoresis. Polymerase chain reaction (PCR)-based methods are cheaper, faster, and easier to perform, but discriminatory power varies depending on the primer used. In this study, we tested the competence of enterobacterial repetitive intergenic consensus (ERIC) PCR in comparison with PFGE to distinguish unrelated isolates (24 Mycobacterium chelonae and 24 M. abscessus) obtained from human and/or environmental samples and to group 56 isolates from 6 outbreaks confirmed epidemiologically, caused by M. chelonae and M. abscessus after ophthalmologic refractive surgery and mesotherapy. Enterobacterial repetitive intergenic consensus PCR presented discriminatory power, calculated using Simpson's index of diversity, of 0.989 for M. abscessus and 0.975 for M. chelonae and grouped outbreak isolates in distinct groups showing epidemiologic concordance. Pulsed-field gel electrophoresis also grouped outbreak isolates and presented discriminatory power of 0.972 and 0.993 for M. abscessus and M. chelonae, respectively. DNA from 8 (22%) of 36 M. abscessus isolates analyzed showed degradation during electrophoresis. Compared with PFGE and epidemiologic information as the gold standard, ERIC PCR is a simple, high throughput, affordable, reproducible, and discriminatory molecular typing method for inference of genetic relatedness of RGMs of the M. chelonae-abscessus group.


Asunto(s)
ADN Intergénico/genética , Secuencias Repetitivas Esparcidas/genética , Infecciones por Mycobacterium/microbiología , Mycobacterium/clasificación , Mycobacterium/genética , Reacción en Cadena de la Polimerasa/métodos , Técnicas Bacteriológicas , ADN Bacteriano/genética , Brotes de Enfermedades , Electroforesis en Gel de Campo Pulsado , Infecciones Bacterianas del Ojo/diagnóstico , Infecciones Bacterianas del Ojo/epidemiología , Infecciones Bacterianas del Ojo/microbiología , Regulación Bacteriana de la Expresión Génica , Humanos , Infecciones por Mycobacterium/diagnóstico , Infecciones por Mycobacterium/epidemiología , Filogenia , Enfermedades Cutáneas Bacterianas/diagnóstico , Enfermedades Cutáneas Bacterianas/epidemiología , Enfermedades Cutáneas Bacterianas/microbiología
20.
Braz J Microbiol ; 47 Suppl 1: 31-37, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27825605

RESUMEN

During the last 30 years there has been a dissemination of plasmid-mediated ß-lactamases in Enterobacteriaceae in Brazil. Extended spectrum ß-lactamases (ESBL) are widely disseminated in the hospital setting and are detected in a lower frequency in the community setting. Cefotaximases are the most frequently detected ESBL type and Klebsiella pneumoniae is the predominant species among ESBL producers. Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae became widely disseminated in Brazil during the last decade and KPC production is currently the most frequent resistance mechanism (96.2%) in carbapenem resistant K. pneumoniae. To date KPC-2 is the only variant reported in Brazil. Polymyxin B resistance in KPC-2-producing K. pneumoniae has come to an alarming rate of 27.1% in 2015 in São Paulo, the largest city in Brazil. New Delhi metallo-ß-lactamase was detected in Brazil in 2013, has been reported in different Brazilian states but are not widely disseminated. Antimicrobial resistance in Enterobacteriaceae in Brazil is a very serious problem that needs urgent actions which includes both more strict adherence to infection control measures and more judicious use of antimicrobials.


Asunto(s)
Antiinfecciosos/farmacología , Farmacorresistencia Bacteriana , Infecciones por Enterobacteriaceae/epidemiología , Infecciones por Enterobacteriaceae/microbiología , Enterobacteriaceae/efectos de los fármacos , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Antiinfecciosos/uso terapéutico , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Brasil/epidemiología , Enterobacteriaceae/enzimología , Enterobacteriaceae/genética , Humanos , Plásmidos/genética , Polimixinas/farmacología , Polimixinas/uso terapéutico , beta-Lactamasas/genética , beta-Lactamasas/metabolismo , beta-Lactamas/farmacología , beta-Lactamas/uso terapéutico
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda